OCEANSIDE, Calif., Jan. 18, 2019 /PRNewswire/ — AOTI Inc. announced today that it has entered into a major strategic relationship with a leading Chinese medical company, Nanning Xinzizhu Trading Co.,Ltd, for distribution of its patented Topical Wound Oxygen...
OCEANSIDE, Calif., Oct. 18, 2018 /PRNewswire/ — AOTI Inc. announced today that it will participate at Jefferies 2018 London Healthcare Conference, being held on November 14 and 15, 2018 in London, United Kingdom. Now in its ninth year, the Jefferies conference...
OCEANSIDE, Calif., Oct. 11, 2018 /PRNewswire/ — AOTI Inc. announced today that expanded results from its recently concluded Randomized Controlled Trial (RCT) demonstrating the efficacy of its patented multi-modality Topical Wound Oxygen (TWO2) homecare therapy...
OCEANSIDE, Calif., Aug. 8, 2018 /PRNewswire/ — AOTI Inc. announced today the opening of an expanded manufacturing facility in Galway, Ireland for the production of its patented Topical Wound Oxygen (TWO2) therapy devices. The new dedicated facility will be...
AOTI Inc. announced today that initial results from its recently concluded Randomized Controlled Trial (RCT) demonstrating the efficacy of its patented multi-modality Topical Wound Oxygen (TWO2) homecare therapy in healing Diabetic Foot Ulcers were presented as a...
OCEANSIDE, Calif., May 22, 2018 /PRNewswire/ — AOTI Inc. announced today that two study abstracts were presented demonstrating Topical Wound Oxygen (TWO2) healing effectiveness in 115 recalcitrant chronic ulcerations of varied etiologies at both the recent...
